| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/27/2003 | US20030059769 High affinity nucleic acid ligands to lectins |
| 03/27/2003 | US20030059767 Zinc finger protein derivatives and methods therefor |
| 03/27/2003 | US20030059764 Apparatus for use in the detection and analysis of preferential cells in sample |
| 03/27/2003 | US20030059763 Nucleotidesequences coding polypeptide for use as tools in human therapeutics |
| 03/27/2003 | US20030059443 Polynucleotides comprising molecular interaction sites of hepatitis C virus RNA that have particular secondary structure; for modulating the activity of hepatitis C virus RNA |
| 03/27/2003 | US20030059433 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 03/27/2003 | US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2003 | US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression |
| 03/27/2003 | US20030059094 Method of extracting locations of nucleic acid array features |
| 03/27/2003 | US20030058799 Nucleic acid sequencing by raman monitoring of molecular deconstruction |
| 03/27/2003 | US20030058672 Associative memory circuit judging whether or not a memory cell content matches search data by performing a differential amplification to a potential of a match line and a reference potential |
| 03/27/2003 | US20030057094 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field |
| 03/27/2003 | CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/27/2003 | CA2472023A1 Method for evaluating a patient's biological condition |
| 03/27/2003 | CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 03/27/2003 | CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 03/27/2003 | CA2460817A1 A method for identifying effector molecules for gene network integration |
| 03/27/2003 | CA2460812A1 Lipid-associated molecules |
| 03/27/2003 | CA2460808A1 Immune response associated proteins |
| 03/27/2003 | CA2460805A1 Nanomachine compositions and methods of use |
| 03/27/2003 | CA2460771A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics |
| 03/27/2003 | CA2460721A1 Genetic analysis for stratification of cancer risk |
| 03/27/2003 | CA2460700A1 Asparagine hydroxylation of the cad domain of a hif protein |
| 03/27/2003 | CA2460652A1 Compositions and methods to identify haplotypes |
| 03/27/2003 | CA2460639A1 Engineered templates and their use in single primer amplification |
| 03/27/2003 | CA2460560A1 Kits and methods for determining the effectiveness of sterilization or disinfection processes |
| 03/27/2003 | CA2460546A1 Dna polymerases and mutants thereof |
| 03/27/2003 | CA2460456A1 Chromogenic in situ hybridization methods, kits, and compositions |
| 03/27/2003 | CA2460317A1 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets |
| 03/27/2003 | CA2460130A1 Method for detecting sepsis |
| 03/27/2003 | CA2460128A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter |
| 03/27/2003 | CA2460073A1 Embossed test strip system |
| 03/27/2003 | CA2459972A1 Differential diagnosis of disorders of iron metabolism by means of three independent parameters and recommendations for the treatment of these disorders of iron metabolism |
| 03/27/2003 | CA2459761A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives |
| 03/27/2003 | CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| 03/27/2003 | CA2459140A1 Protein modification and maintenance molecules |
| 03/27/2003 | CA2459022A1 Neurotransmission-associated proteins |
| 03/27/2003 | CA2458303A1 Brain expressed cap-2 gene and protein associated with bipolar disorder |
| 03/27/2003 | CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma |
| 03/27/2003 | CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 03/27/2003 | CA2423849A1 Method for determining the age of individuals |
| 03/26/2003 | EP1296334A2 Associative memory with matching circuit with differential amplification |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules |
| 03/26/2003 | EP1295951A1 Cell library method |
| 03/26/2003 | EP1295950A1 Expression profiling |
| 03/26/2003 | EP1295949A1 Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use |
| 03/26/2003 | EP1295948A2 Method of measurement of protease and thin membranes used for said method |
| 03/26/2003 | EP1295947A1 Method of measuring total homocysteine |
| 03/26/2003 | EP1295945A1 Human neuronal nictinic acetylcholine receptor compositions and mehtods employing same |
| 03/26/2003 | EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins |
| 03/26/2003 | EP1295941A1 Novel nucleic acid probes and method of assaying nucleic acid by using the same |
| 03/26/2003 | EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby |
| 03/26/2003 | EP1295643A1 Liquid droplet ejecting method and a liquid droplet ejection apparatus |
| 03/26/2003 | EP1295238A2 Clustering method |
| 03/26/2003 | EP1295128A2 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit |
| 03/26/2003 | EP1295127A2 Inter-alpha-trypsin as a marker for sepsis |
| 03/26/2003 | EP1294952A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 03/26/2003 | EP1294951A2 Diagnosis of diseases associated with the immune system |
| 03/26/2003 | EP1294950A2 Diagnosis of diseases associated with development genes |
| 03/26/2003 | EP1294948A2 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 03/26/2003 | EP1294947A2 Method and nucleic acids for pharmacogenomic methylation analysis |
| 03/26/2003 | EP1294946A2 Multiplex sequencing method |
| 03/26/2003 | EP1294945A2 Method for detecting cytosine methylations |
| 03/26/2003 | EP1294944A2 Detection of nucleic acids by type-specific hybrid capture method |
| 03/26/2003 | EP1294943A2 RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE |
| 03/26/2003 | EP1294942A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods |
| 03/26/2003 | EP1294941A1 Method for i in vitro /i diagnosis of prostatic cancer and kit therefor |
| 03/26/2003 | EP1294940A2 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 03/26/2003 | EP1294939A2 Detection and typing of human papillomavirus using pna probes |
| 03/26/2003 | EP1294938A2 Cell-binding nucleic acid molecules (aptamers) |
| 03/26/2003 | EP1294937A2 Beta2 adrenergic receptor polymorphism detection |
| 03/26/2003 | EP1294936A2 High throughput methods for haplotyping |
| 03/26/2003 | EP1294935A2 Compositions and methods for simultaneous detection of multiple biological entities |
| 03/26/2003 | EP1294934A2 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 03/26/2003 | EP1294933A2 Method for reducing artifacts in nucleic acid amplification |
| 03/26/2003 | EP1294931A1 Screening methods for gram-positive enterococcal virulence factors |
| 03/26/2003 | EP1294930A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/26/2003 | EP1294929A1 Method to detect modulators of vegf kinase domain |
| 03/26/2003 | EP1294928A1 Screening method for modulators of suv39h2-methyltransferase |
| 03/26/2003 | EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 03/26/2003 | EP1294926A2 Test system for determining the activity of cyclo-nucleotide-dependent protein kinases and vasp phosphatases |
| 03/26/2003 | EP1294925A2 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target |
| 03/26/2003 | EP1294924A2 Method for identifying medically valuable active substances |
| 03/26/2003 | EP1294923A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 03/26/2003 | EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 03/26/2003 | EP1294909A2 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 03/26/2003 | EP1294906A2 Whole-body optical imaging of gene expression and uses thereof |
| 03/26/2003 | EP1294901A2 Novel proteases |
| 03/26/2003 | EP1294895A2 Calpain protease 12 |
| 03/26/2003 | EP1294888A2 Interferon-like protein zcyto21 |
| 03/26/2003 | EP1294885A2 B7-like molecules and uses thereof |
| 03/26/2003 | EP1294884A2 Secretion and trafficking molecules |
| 03/26/2003 | EP1294883A2 Human extracellular matrix (ecm)-related tumor marker |
| 03/26/2003 | EP1294882A2 B7-like molecules and uses thereof |
| 03/26/2003 | EP1294881A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 03/26/2003 | EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 03/26/2003 | EP1294877A2 Cgi-69 compositions and methods of use |
| 03/26/2003 | EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/26/2003 | EP1294873A1 Tumour suppressor and uses thereof |